ACAD
ACADIA Pharmaceuticals Inc
22.20$
-12.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 6.9% | 7.7% | 11.2% | 7.5% | 7.5% | 8.4% | 8.3% | 7.8% | 7.8% | 9.2% | 9.2% | 9.2% | 8.9% | |
| 93.1% | 92.3% | 88.8% | 92.5% | 92.5% | 91.6% | 91.7% | 92.2% | 92.2% | 90.8% | 90.8% | 90.8% | 91.1% | |
| 74.1% | 28.9% | 29.0% | 31.5% | 26.6% | 38.8% | 32.0% | 29.5% | 31.5% | 29.8% | 28.7% | 26.5% | 29.1% | |
| 46.2% | 44.2% | 52.5% | 48.4% | 53.2% | 50.1% | 51.7% | 50.5% | 47.9% | 54.8% | 63.8% | 52.0% | 54.5% | |
| 120.4% | 77.1% | 81.5% | 79.9% | 79.8% | 32.5% | 83.8% | 79.9% | 79.4% | 84.6% | 92.5% | 78.5% | 83.5% | |
| -27.3% | 15.1% | 7.4% | 12.6% | 12.6% | 59.1% | 7.9% | 12.2% | 12.8% | 6.1% | -1.7% | 12.3% | 7.6% | |
| -24.6% | 17.2% | 10.2% | 15.4% | 15.5% | 62.1% | 11.4% | 15.2% | 16.0% | 9.3% | 1.5% | 15.1% | 10.7% | |
| 6.2% | -2.6% | 2.2% | 1.6% | 2.4% | 6.7% | 3.6% | 5.1% | -9.8% | -87.1% | 0.1% | 4.9% | -22.8% | |
| -30.8% | 19.8% | 8.0% | 13.8% | 13.1% | 55.4% | 7.8% | 10.1% | 25.8% | 96.3% | 1.4% | 10.2% | 33.4% | |
| -23.8% | 17.9% | 12.9% | 16.4% | 16.5% | 4.7% | 12.6% | 16.3% | 17.1% | 10.3% | 2.6% | 10.5% | 10.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.